Evidence map›Paper›PMID 24672804›Full record

ReviewJournal of diabetes research2014

Decompensation of β-cells in diabetes: when pancreatic β-cells are on ICE(R).

Roberto Salvi, Amar Abderrahmani

Open access · goldAbstract readReview
In one paragraph

Review in Journal of diabetes research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Roberto SalviEuropean Genomic Institute for Diabetes (EGID), Lille 2 University, UMR 8199, 3508 Lille, France.
Amar AbderrahmaniEuropean Genomic Institute for Diabetes (EGID), Lille 2 University, UMR 8199, 3508 Lille, France ; Faculty of Medicine West, 1 Place de Verdun, 59045 Lille, France.ORCID 0000-0003-0752-0343
European Genomic Institute for Diabetes · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin production and secretion are temporally regulated. Keeping insulin secretion at rest after a rise of glucose prevents exhaustion and ultimately failure of β-cells. Among the mechanisms that reduce β-cell activity is the inducible cAMP early repressor (ICER). ICER is an immediate early gene, which is rapidly induced by the cyclic AMP (cAMP) signaling cascade. The seminal function of ICER is to negatively regulate the production and secretion of insulin by repressing the genes expression. This is part of adaptive response required for proper β-cells function in response to environmental factors. Inappropriate induction of ICER accounts for pancreatic β-cells dysfunction and ultimately death elicited by chronic hyperglycemia, fatty acids, and oxidized LDL. This review underlines the importance of balancing the negative regulation achieved by ICER for preserving β-cell function and survival in diabetes.

Indexed as

AllostasisGene Expression RegulationModels, BiologicalAnimalsCyclic AMPCyclic AMP Response Element ModulatorDiabetes MellitusDisease ProgressionDown-RegulationHumansInsulinInsulin-Secreting CellsInsulin SecretionSecond Messenger SystemsStress, PhysiologicalCREM protein, humanCyclic AMPCyclic AMP Response Element ModulatorInsulin

Identifiers

PMID24672804
PMCPMC3941242
OpenAlexW2019903781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.